SRMR: Software Refraction With Mobilerone Versus Retinoscopy

Sponsor
Beijing Airdoc Technology Co., Ltd. (Industry)
Overall Status
Recruiting
CT.gov ID
NCT06059521
Collaborator
University of Notre Dame Australia (Other)
120
3
2
89.5
40
0.4

Study Details

Study Description

Brief Summary

Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.

Condition or Disease Intervention/Treatment Phase
  • Device: Software refraction with Eye Test Technology in a mobilerone
  • Device: Retinoscopy
N/A

Detailed Description

It's a software installed in a mobilerone with subjective guide on screen for testing myopic refractive error with or without astigmatism for adults or elder children. The investigators would like to compare its refraction results with retinoscopy.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Randomized Controlled Study on Subjective Refraction by Software Eye Test Technology Versus Retinoscopy
Actual Study Start Date :
Jul 15, 2023
Anticipated Primary Completion Date :
Dec 30, 2025
Anticipated Study Completion Date :
Dec 30, 2030

Arms and Interventions

Arm Intervention/Treatment
Experimental: Software Refraction

Refraction is done by software with subjective refraction through a mobilerone.

Device: Software refraction with Eye Test Technology in a mobilerone
Refraction is done by software App by a mobilerone software installed.
Other Names:
  • Online refraction or App refraction with Eye Test Technology
  • Active Comparator: Refraction by retinoscopy

    Refraction is done objectively by retinoscopy.

    Device: Retinoscopy
    Retinoscopy is an objective refraction method with retinoscope.
    Other Names:
  • Refraction by retinoscopy
  • Outcome Measures

    Primary Outcome Measures

    1. Spherical Equivalence(D) [1-day and within 2 weeks]

      Spherical is myopic equivalence with total spherical plus half the cylinder diopter.

    2. Astigmatism Power(D) [1-day and within 2 weeks]

      Cylinder value of each total astigmatism power

    3. Astigmatism axial [1-day and within 2 weeks]

      Cylinder axis of astigmatism

    4. pupil distance (mm) [1-day and within 2 weeks]

      pupil distance measurement with software or autorefractor

    Secondary Outcome Measures

    1. Efficacy of test time (minutes) [1-day and within 2 eeks]

      How long for each test

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    10 Years to 46 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • • subject with ametropia on each eye ≤-12.00D

    • subject with best corrected visual acuity ≥ 20/25, no amblyopia

    • subject with normal transparency of eyes

    • subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations

    • subject able to cooperate with the screen and the operator

    • subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids

    • non-diabetic subject

    • non nystagmus subject

    • non-strabismus subject

    • subject who has not had eye surgery less than 1 year old

    Exclusion Criteria:
    • • subject with a topography showing an anomaly (keratoconus type or other)

    • subject with hyperopia or presbyopia

    • subject with mild myopia ≥ -1.00D

    • subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Airdoc MPC Opthalmology Clinics Beijing Beijing China 100089
    2 Jenny QIU Beijing Beijing China 100089
    3 Qiu Jenny Beijing Haidian District China 100089

    Sponsors and Collaborators

    • Beijing Airdoc Technology Co., Ltd.
    • University of Notre Dame Australia

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Beijing Airdoc Technology Co., Ltd.
    ClinicalTrials.gov Identifier:
    NCT06059521
    Other Study ID Numbers:
    • AirdocSoftwareEyeTest
    First Posted:
    Sep 28, 2023
    Last Update Posted:
    Sep 28, 2023
    Last Verified:
    Sep 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Beijing Airdoc Technology Co., Ltd.
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 28, 2023